| PERIOD ENDING | 25-Sep-09 | 26-Jun-09 | 27-Mar-09 | 26-Dec-08 | | Total Revenue | 147,308 | 147,712 | 137,880 | 166,689 | | Cost of Revenue | 69,167 | 74,704 | 73,552 | 85,288 | | | Gross Profit | 78,141 | 73,008 | 64,328 | 81,401 | | | Operating Expenses | | Research Development | 8,752 | 9,781 | 10,051 | 9,953 | | Selling General and Administrative | 43,202 | 44,781 | 48,148 | 56,029 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 26,187 | 18,446 | 6,129 | 15,419 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (203) | (91) | (595) | (547) | | Earnings Before Interest And Taxes | 25,984 | 18,355 | 5,534 | 14,872 | | Interest Expense | 1,148 | 1,221 | 1,366 | 2,190 | | Income Before Tax | 24,836 | 17,134 | 4,168 | 12,682 | | Income Tax Expense | 7,500 | 5,500 | 1,400 | 2,600 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 17,336 | 11,634 | 2,768 | 10,082 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 17,336 | 11,634 | 2,768 | 10,082 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $17,336 | $11,634 | $2,768 | $10,082 |
|
0.22% Nasdaq 
Income Statement
